ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
- To compare the Kinetics of inhibition of platelet aggregation (aggregometry) and
platelet activation (flow cytometry) with different loading doses of clopidogrel
- To evaluate the effect on various parameters of inflammation and necrosis and the safety
of these loading doses